![Mitchell Glass](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 10 638 $ in data 30/09/2026
Dr. Mitchell Glass, MD, is a Director & Chief Medical Officer at Q/C Technologies, Inc., a Chairman at Accolade Pharma LLC and a Chief Executive Officer & Director at Chronic Airway Therapeutics Pty Ltd. He is on the Board of Directors at Q/C Technologies, Inc., Avatar Biotechnologies LLC, Orphagenix, Inc. and Chronic Airway Therapeutics Pty Ltd. Dr. Glass was previously employed as a Chief Medical Officer by Invion Ltd., a Chief Executive Officer by Aqumen Biopharmaceuticals NA, Inc., a Chief Scientific Officer by University City Science Center, a Chief Medical Officer & VP-Regulatory Affairs by AtheroGenics, Inc., a Director & Vice President by Smithkline Beecham Corp., a Principal by ICI Pharmaceuticals, a Chief Executive Officer by Aqumen Biopharmaceuticals KK, a Principal by Inverseon, Inc., a Chief Medical Officer & EVP-Research & Development by Invion Ltd., and a Principal by University of Pennsylvania.
He received his undergraduate degree from The University of Chicago and a doctorate degree from The University of Chicago.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 26/04/2026 | 12.500 ( 0,15% ) | 10 638 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| Q/C TECHNOLOGIES, INC. | Direttore Tecnico/Scientifico/R&S | 13/06/2024 |
Accolade Pharma LLC
 Accolade Pharma LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Presidente | - |
Chronic Airway Therapeutics
 Chronic Airway Therapeutics BiotechnologyHealth Technology Develops treatments for chronic respiratory diseases | Amministratore Delegato | - |
Avatar Biotechnologies LLC | Direttore/Membro del Consiglio | 13/04/2010 |
Orphagenix, Inc. | Direttore/Membro del Consiglio | 13/04/2010 |
| Società | Posizione | Fine |
|---|---|---|
| INVION LIMITED | Direttore Tecnico/Scientifico/R&S | 01/03/2019 |
| INVION LIMITED | Direttore/Membro del Consiglio | 12/02/2019 |
Inverseon, Inc.
 Inverseon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Corporate Officer/Principal | 01/09/2012 |
Aqumen Biopharmaceuticals NA, Inc. | Presidente | 02/01/2008 |
| ░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 15 |
|---|---|
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Orphagenix, Inc. | |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University City Science Center
 University City Science Center Investment Trusts/Mutual FundsMiscellaneous Provides physical space, resources and other support to the community | Miscellaneous |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Aqumen Biopharmaceuticals KK
 Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Develops and researches therapeutic medicines | Health Technology |
Inverseon, Inc.
Inverseon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Aqumen Biopharmaceuticals NA, Inc. | |
Avatar Biotechnologies LLC | |
Invion Ltd.
 Invion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Health Technology |
Accolade Pharma LLC
Accolade Pharma LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
MyMD Pharmaceuticals, Inc.
 MyMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that engages in the development of drug products to extend healthy lifespan | Health Technology |
Chronic Airway Therapeutics
Chronic Airway Therapeutics BiotechnologyHealth Technology Develops treatments for chronic respiratory diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
